• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性HIV感染中HIV-1 DNA和RNA的动力学

HIV-1 DNA and RNA kinetics in primary HIV infection.

作者信息

Lillo F, Grasso M, Lodini S, Capiluppi B, Lazzarin A, Tambussi G

机构信息

Laboratory of Virology, Scientific Institute San Raffaele, Milan, Italy.

出版信息

J Biol Regul Homeost Agents. 2002 Jan-Mar;16(1):49-52.

PMID:12003174
Abstract

BACKGROUND

HIV-1 reservoir is early established during PHI. It is reduced, but not extinguished by early therapy: DNA containing cells are still detectable after months of successful viremia suppression. To define the best method to measure low level viral replication, we determined the extent of HIV reservoir in 11 acutely infected patients and evaluated how it is renewed even during successful treatment.

METHODS

Eleven acutely infected HIV patients were included in the study. Three where not treated with antiretroviral drugs while 8 underwent early aggressive antiretroviral treatment (HAART) which, in 3 cases, was associated to cyclosporin A (CsA) administration. HIV viremia was monitored by commercially available methods while HIV-DNA and cellular RNA quantitation were obtained by in house PCR and RT-PCR respectively, in the gag region.

RESULTS

Significant CD4 recover and HIV viremia suppression were reached in a mean period of three to six months in all treated patients. The course of the HIV-DNA and of cellular HIV RNA reduction showed a similar trend. This variation was slower, if compared to plasma viremia and never reached undetectable levels, justifying the rebound of viremia observed at therapy interruption.

CONCLUSIONS

These data suggest and confirm that complete abolition of viral replication is not achieved and viral reservoir may be re-expanded even after short term rebound of viremia. Scheduling of possible structured therapy interruption should be designed based on multiple virological parameters and on the individual characteristics of the patients.

摘要

背景

HIV-1储存库在PHI期间早期建立。它会减少,但早期治疗无法将其消除:在成功抑制病毒血症数月后,仍可检测到含DNA的细胞。为了确定测量低水平病毒复制的最佳方法,我们测定了11例急性感染患者的HIV储存库程度,并评估了即使在成功治疗期间它是如何更新的。

方法

11例急性感染HIV的患者纳入本研究。3例未接受抗逆转录病毒药物治疗,而8例接受了早期积极的抗逆转录病毒治疗(HAART),其中3例联合使用环孢素A(CsA)。通过商用方法监测HIV病毒血症,同时分别通过内部PCR和RT-PCR在gag区域进行HIV-DNA和细胞RNA定量。

结果

所有接受治疗的患者在三到六个月的平均时间内实现了显著的CD4恢复和HIV病毒血症抑制。HIV-DNA和细胞HIV RNA减少的过程显示出相似的趋势。与血浆病毒血症相比,这种变化较慢,且从未达到不可检测的水平,这解释了在治疗中断时观察到的病毒血症反弹。

结论

这些数据表明并证实,即使在病毒血症短期反弹后,也无法完全消除病毒复制,病毒储存库可能会重新扩大。应根据多种病毒学参数和患者的个体特征来设计可能的结构化治疗中断计划。

相似文献

1
HIV-1 DNA and RNA kinetics in primary HIV infection.原发性HIV感染中HIV-1 DNA和RNA的动力学
J Biol Regul Homeost Agents. 2002 Jan-Mar;16(1):49-52.
2
Detection and quantification of proviral HIV-1 184 M/V in circulating CD4(+) T cells of patients on HAART with a viremia less than 1,000 copies/ml.在接受高效抗逆转录病毒治疗(HAART)且病毒血症低于1000拷贝/毫升的患者循环CD4(+) T细胞中检测和定量原病毒HIV-1 184 M/V 。
J Clin Virol. 2005 Dec;34(4):257-67. doi: 10.1016/j.jcv.2005.02.015. Epub 2005 Apr 18.
3
Virological characterization of patients treated early is able to control HIV-1 replication after multiple cycles of structured therapy interruption.早期接受治疗的患者的病毒学特征能够在多次结构化治疗中断循环后控制HIV-1复制。
J Med Virol. 2007 Aug;79(8):1047-54. doi: 10.1002/jmv.20895.
4
Long-term suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug-resistant genotypes.尽管病毒发生了进化且耐药基因型的选择非常有限,但高效抗逆转录病毒疗法仍能长期抑制血浆病毒血症。
J Med Virol. 2004 Jul;73(3):350-61. doi: 10.1002/jmv.20098.
5
Molecular biological assessment methods and understanding the course of the HIV infection.分子生物学评估方法与对HIV感染病程的理解
APMIS Suppl. 2003(114):1-37.
6
HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.单次治疗中断后HIV-1病毒反弹动力学取决于高效抗逆转录病毒疗法开始的时间。
AIDS. 2008 Aug 20;22(13):1583-8. doi: 10.1097/QAD.0b013e328305bd77.
7
Successful simplification of HAART in patients with acute primary HIV infection.急性原发性HIV感染患者高效抗逆转录病毒治疗的成功简化
J Biol Regul Homeost Agents. 2002 Jan-Mar;16(1):69-72.
8
HIV-1 resistant strains acquired at the time of primary infection massively fuel the cellular reservoir and persist for lengthy periods of time.初次感染时获得的HIV-1耐药毒株大量填充细胞储存库,并长期持续存在。
AIDS. 2006 Jan 9;20(2):159-70. doi: 10.1097/01.aids.0000199820.47703.a0.
9
Residual viraemia in HIV-1-infected patients with plasma viral load <or=20 copies/ml is associated with increased blood levels of soluble immune activation markers.血浆病毒载量≤20拷贝/毫升的HIV-1感染患者的残余病毒血症与可溶性免疫激活标志物的血液水平升高有关。
Scand J Immunol. 2008 Dec;68(6):652-60. doi: 10.1111/j.1365-3083.2008.02184.x.
10
Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia.原发性人类免疫缺陷病毒1型(HIV-1)感染的强效抗逆转录病毒疗法:尽管血浆病毒血症已清除,但T淋巴细胞亚群部分恢复正常,且HIV-1 DNA仅有限减少。
J Infect Dis. 1999 Aug;180(2):320-9. doi: 10.1086/314880.

引用本文的文献

1
Incident Kaposi sarcoma during the expansion of antiretroviral therapy eligibility in Nigeria: a retrospective cohort study.在尼日利亚扩大抗逆转录病毒治疗资格期间发生卡波西肉瘤:一项回顾性队列研究。
BMC Cancer. 2023 Sep 21;23(1):890. doi: 10.1186/s12885-023-11402-3.
2
Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infection.原发和慢性 HIV 感染开始启动治疗方案指示中断 ART 后血浆 HIV 病毒反弹。
PLoS One. 2012;7(8):e43754. doi: 10.1371/journal.pone.0043754. Epub 2012 Aug 31.
3
Viral load and CD4+ T-cell dynamics in primary HIV-1 subtype C infection.
原发性HIV-1 C亚型感染中的病毒载量和CD4+ T细胞动态变化
J Acquir Immune Defic Syndr. 2009 Jan 1;50(1):65-76. doi: 10.1097/QAI.0b013e3181900141.